Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies

Published:2015-11-20 Issue:1 Volume:2 Page:
ISSN:2194-7791
Container-title:Molecular and Cellular Pediatrics
language:en
Short-container-title:Mol Cell Pediatr

Author:

Antony Justin S.,Dewerth Alexander,Haque Ashiqul,Handgretinger Rupert,Kormann Michael S.D.

Funder

Deutsche Forschungsgemeinschaft

European Research Council (BE)

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40348-015-0022-6.pdf

Reference33 articles.

1. Gibson GJ, Loddenkemper R, Lundback B, Sibille Y (2013) Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J 42(3):559–563. doi: 10.1183/09031936.00105513

2. Zar HJ, Ferkol TW (2014) The global burden of respiratory disease—impact on child health. Pediatr Pulmonol 49(5):430–434. doi: 10.1002/ppul.23030

3. Zar HJ, Mulholland K (2003) Global burden of pediatric respiratory illness and the implications for management and prevention. Pediatr Pulmonol 36(6):457–461. doi: 10.1002/ppul.10345

4. Higgs DR, Engel JD, Stamatoyannopoulos G (2012) Thalassaemia. Lancet 379(9813):373–383. doi: 10.1016/S0140-6736(11)60283-3

5. Ngo DA, Steinberg MH (2015) Genomic approaches to identifying targets for treating beta hemoglobinopathies. BMC Med Genomics 8(1):44. doi: 10.1186/s12920-015-0120-2

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential in vivo;Molecular Therapy - Nucleic Acids;2023-12

2. Hematogenous Routing of Exogenous Messenger RNA Delivered Into the Amniotic Fluid;Journal of Surgical Research;2023-09

3. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA;International Journal of Pharmaceutics;2023-06

4. Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens;RNA Therapeutics;2022

5. Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments;Pharmaceutics;2020-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3